LevitasBio

San Francisco, United States

LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.

$11.8M raised

Mar 2024

Venture - Series Unknown

Top Investors

Pavilion CapitalDecheng CapitalNovalis LifeSciences

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has LevitasBio raised?

LevitasBio has raised $11.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2024.

Who are LevitasBio's investors?

LevitasBio's investors include Pavilion Capital, Decheng Capital, Novalis LifeSciences.

Where is LevitasBio headquartered?

LevitasBio is headquartered in San Francisco, United States.

What does LevitasBio do?

LevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.

What stage is LevitasBio at?

LevitasBio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 28, 2024.

MLA

"LevitasBio — Funding & Investors." VCBacked, March 28, 2024, https://www.vcbacked.co/company/levitasbio. Accessed June 16, 2026.

APA

VCBacked. (2024). LevitasBio — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/levitasbio

Wikipedia (cite web)

{{cite web |title=LevitasBio — Funding & Investors |url=https://www.vcbacked.co/company/levitasbio |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 28, 2024.